SignalXSignalX

ALEC Alector, Inc.

8-K Current Report
Filed: February 25, 2026
Health Care
Biological Products, (No Diagnostic Substances)
Alector, Inc. Overview

Alector, Inc. (ALEC) 8-K current report filed with SEC EDGAR on February 25, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

  • Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

  • • Q4 2025 earnings release filed; full financial details in Exhibit 99.1 press release
  • • Reporting period: quarter ended December 31, 2025
+1 more insights

Get deeper insights on Alector, Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.